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Introduction: Colorectal cancer is one of the most commonly diagnosed cancers in 
the world. The main and classic treatment of this cancer is 5-fluorouracil (5-Fu) that 
its cytotoxicity and low systemic absorption restricted its therapeutic efficacy. To 
overcome these problems, mucoadhesive and colonic microbially degradable 
formulations based on chitosan and dextran sulphate hydrogels could be effective. 
Methods and Results: 5-Fu loaded hydrogel microparticles were formed via 
polyelectrolyte complexation technique using chitosan and dextran sulphate 
solutions. It was optimized by a systematic multi-objective optimization approach in 
terms of the particle size and loading efficiency of the resulting microparticles. 
Under this condition, the molecular weight of chitosan and 5-Fu concentration are 
the two factors which significantly influence the particle size and loading efficiency, 
respectively. Then the optimized microparticles were prepared and were 
characterized based on particle size, zeta potential, drug loading and drug release 
behavior. Finally the cytotoxicity of optimized microparticles was assessed by MTT 
assay (SW742 cell line) compare to free drug solution. Therefore, spherical particles 
of 51.33±0.95 μm mean diameter and a narrow size distribution were obtained under 
optimal conditions. The zeta potential, loading efficiency and loading capacity of 
optimized microparticles were 18.1±0.87mv, 26.96±0.38 and 13.12±0.65%, 
respectively. The in vitro drug release profile was fitted on Higuchi model and the 
cytotoxicity MTT results indicated the higher cytotoxicity of studied formulation on 
cells compare to free drug. The hydrogel microparticles were further lyophilized to 
prepare the enteric coated tablets and all tests endorsed that the coating process was 
suited. 
Conclusions: 
The designed formulations have provided appropriate properties and offer a potential 
mean for colon specific delivery of 5-Fu via oral administration. 
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